D
Design Therapeutics, Inc. (DSGN)
NMS – Real Time Price. Currency in USD
10.53
-0.18 (-1.68%)
At close: Mar 27, 2026, 4:00 PM EDT
10.53
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT

NMS – Real Time Price. Currency in USD
10.53
-0.18 (-1.68%)
At close: Mar 27, 2026, 4:00 PM EDT
10.53
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 17.14 | 6.05 | 10 | |
| Quick ratio | 17.14 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -466K | -537K | -596K | -622K | -622K |
| Operating Income | -68M | -78M | -62M | -79M | -79M |
| Net Income | -63M | -67M | -50M | -70M | -70M |
| EBITDA | -67M | -78M | -62M | -79M | -79M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -2.15 | 1.0 |
| Next quarter | N/A | -0.98 | 1.0 |
| Current year | N/A | -11.75 | 1.0 |
| Next year | N/A | -20.42 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 5.88 | 10 | -7.5 | 5.5 |
| Y/Y | 999 | -17.18 | -12.49 | -21.69 | 3.3 |
| 3y average | 999 | -6.82 | -5.64 | -3.69 | 3.3 |
| 5y average | 999 | -85.55 | -41.11 | -66.98 | 3.3 |
| Weighted average score | 3.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $16.9M significantly exceed its total debt $1.5M, ensuring strong financial flexibility
Total current assets $223.8M exceed Total current liabilities $13.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$12.0M limits the company's ability to reinvest or pay down debt